Knowledge related to SARS-CoV-2 or 2019 novel coronavirus (2019-nCoV) is still emerging and rapidly evolving. We know little about the effects of this novel coronavirus on various body systems and its behaviour among patients with underlying neurological conditions, especially those on immunomodulatory medications. The aim of the present consensus expert opinion document is to appraise the potential concerns when managing our patients with underlying CNS autoimmune demyelinating disorders during the current COVID-19 pandemic.

中文翻译：

---

关于在COVID-19大流行期间多发性硬化症和相关疾病的免疫调节的共识声明：代表印度神经科学院的专家组。

与SARS-CoV-2或2019年新型冠状病毒（2019-nCoV）相关的知识仍在不断涌现并迅速发展。我们对这种新型冠状病毒对各种身体系统的影响及其在具有潜在神经系统疾病的患者（尤其是免疫调节药物患者）中的行为知之甚少。本共识专家意见文件的目的是评估在当前COVID-19大流行期间管理潜在的中枢神经系统自身免疫性脱髓鞘疾病的患者时的潜在担忧。